Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Wellysis Secures FDA 510(k) Clearance for AI-Powered ECG Analysis Software, S-Patch CardioAI

8 October 2026 · By · Wire by Fusion42

Published

8 October 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United States

◆ Source

Read at morningstar.com →

◆ Verified

Fusion42 · 10 October 2026 · Fusion42 review

Wellysis has secured FDA 510(k) clearance for its AI-powered ECG analysis software, S-Patch CardioAI, enabling integration of AI analysis into ECG monitoring platforms and clinical workflows within the US market.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ ◆ The Wire takeaway

AI-driven electrocardiogram analysis is now FDA cleared, opening doors for you in US healthcare to embed advanced AI diagnostics into remote monitoring products this quarter.

◆ Coverage

1 source · 8 Oct 2026

◆ Related on Wire

◆ Topics

Digital Healthfda-clearanceai-analysisecgwearable-healthtechremote-patient-monitoring